Cure My Disease

Don't miss your cure!

 Log in / Sign up

New vaccine aims to better protect transplant patients against COVID-19

NCT ID NCT07390968

Not yet recruiting ⭐️ VACCINE ⭐️ Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated May 01, 2026 · Updated 7 times

Summary

This study tests a new type of COVID-19 vaccine (LUNAR-COV19) in 56 adults who have had a stem cell transplant within the past year. Standard vaccines often don't work as well in these patients because their immune system is weakened. The new vaccine uses a self-amplifying mRNA that may create a stronger and longer-lasting immune response. Researchers will compare it to the standard Pfizer vaccine to see which is safer and more effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM